Chemed Corporation (CHE) — ESG & Values Scores

Environment story

Chemed Corporation operates primarily in service-based businesses (Roto-Rooter plumbing and VITAS hospice care) with limited disclosed environmental management frameworks. The 10-K discloses awareness of environmental compliance obligations but provides no quantified Scope 1, 2, or 3 emissions data, net-zero targets, renewable energy commitments, or decarbonization initiatives. The company acknowledges environmental liabilities from historical operations (DuBois Chemicals cleanup obligations) and recognizes climate-related risks (tariffs on steel, pharmaceutical supply chains). Without verified emissions baselines or documented mitigation strategies, the environmental score reflects significant information gaps and lack of demonstrated commitment to decarbonization targets.

Criticisms on file

Undisclosed Emissions and Decarbonization Strategy
Source: CHE 10-K: No Scope 1, 2, or 3 emissions data; no net-zero target; no renewable energy disclosure
Legacy Environmental Liability from Former Chemical Operations
Source: CHE 10-K Item 1A Risk Factors: 'we have retained certain environmental liabilities in connection with the sale of former businesses' and are 'currently funding the cleanup of historical contamination at one of our former properties'
Tariff-Induced Supply Chain and Cost Pressures
Source: CHE 10-K Item 1A Risk Factors: 'significant tariffs on certain products, such as steel for Roto-Rooter's cabling machines and pharmaceuticals utilized by VITAS, could materially increase the costs'

Disclosed initiatives

Environmental Compliance Program

Company acknowledges compliance with federal, state, and local environmental, health, and safety laws regulating pollutant discharge and employee hazard exposure.
Historical Remediation Obligations

Chemed is funding cleanup of historical contamination at former properties and contributing to third-party site remediation from sale of former subsidiary DuBois Chemicals Inc.

Reserve established; actual cleanup costs may exceed estimates.

Social story

Chemed acknowledges workforce challenges common to service-based healthcare operations, including intense competition for skilled labor (nurses, plumbers, healthcare aides), wage/benefit pressures, and retention difficulties. The 10-K does not disclose CEO-to-worker pay ratios, workforce diversity metrics, gender/racial pay gaps, formal diversity programs, or union-standing details. No documented labor disputes, strikes, or NLRB complaints are mentioned in the filing. The company recognizes the importance of employee training and retention but provides limited transparency on labor practices, supply-chain ethics, or commitment to living wages. Cybersecurity incidents affecting patient data are disclosed for VITAS (October 2025 breach of PHI), indicating data-governance weaknesses.

Criticisms on file

October 2025 Cybersecurity Breach at VITAS — Unauthorized Access to Protected Health Information (PHI)
Source: CHE 10-K Item 1A Risk Factors (Cybersecurity section): 'in October of 2025, access to our systems was gained by a threat actor in a cybersecurity attack. The threat actor was able to access a significant amount of Protected Health Information (PHI)'
Nationwide Nurse and Healthcare Aide Shortages Driving Wage Inflation
Source: CHE 10-K Item 1A Risk Factors: 'A significant portion of VITAS' workforce is licensed nurses... The recent nationwide shortage of qualified nurses impacts some of the markets in which VITAS provides hospice services... Increases in the wages and benefits required to attract and retain qualified nurses... could negatively impact profitability'
Intense Competition for Skilled Plumbers and Technicians at Roto-Rooter
Source: CHE 10-K Item 1A Risk Factors: 'Competition for skilled employees, particularly licensed plumbers, is intense, and the process of locating and recruiting skilled employees... can be difficult and lengthy'
No Disclosed Diversity, Pay Equity, or Union Engagement Metrics
Source: CHE 10-K: Absence of diversity percentages, CEO-to-worker pay ratios, gender/racial pay-gap disclosures, or union-standing information

Disclosed initiatives

Wage and Benefits Adjustments for Nurse and Aide Recruitment

VITAS has adjusted wages and benefits to recruit and retain nurses and to engage contract nurses in response to nationwide shortage of qualified nurses and home health aides.

Increased labor costs may negatively impact profitability; supports workforce stability.
Employee Training and Skilled Labor Development

Company emphasizes importance of attracting, retaining, and training highly skilled personnel across both Roto-Rooter (licensed plumbers) and VITAS (nurses, healthcare workers).
Cybersecurity Response Plan for Data Protection

Both Roto-Rooter and VITAS maintain cybersecurity safeguards, monthly testing, incident response plans, and commercial cyber insurance to protect customer and patient data.

Supports privacy protection for customers and patients; mitigates liability from data breaches.

Governance story

Chemed Corporation's governance disclosures are limited. The 10-K contains no explicit statements on board independence percentage, dual-class share structure, or annual lobbying expenditures. The company acknowledges exposure to various regulatory frameworks (franchising laws, healthcare regulations, environmental compliance) and notes litigation risks inherent to both plumbing and hospice operations. Cybersecurity governance is assigned to the Chief Legal Officer and Chief Financial Officer for materiality assessment. The company is subject to Delaware anti-takeover provisions (Section 203) and notes heightened FTC/antitrust scrutiny of healthcare mergers. No evidence of active antitrust proceedings, SEC consent decrees, or significant regulatory fines is disclosed in the filing. The absence of governance transparency on board composition, voting structures, and political engagement limits assessment against the rubric.

Criticisms on file

No Disclosed Board Independence Percentage or Composition
Source: CHE 10-K: Absence of board independence metrics or governance structure disclosures
No Disclosed Lobbying Expenditures or Political Engagement
Source: CHE 10-K: No lobbying spend, PAC contributions, or trade-association alignment disclosures
Delaware Anti-Takeover Provisions Limit Stockholder Rights
Source: CHE 10-K Item 1A Risk Factors: 'We are subject to the anti-takeover provisions of Section 203 of the Delaware General Corporation Law, which prohibits us from engaging in a "business combination" with an "interested stockholder" for a period of three years'
Heightened FTC/Antitrust Scrutiny of Healthcare Mergers
Source: CHE 10-K Item 1A Risk Factors: 'the FTC and other antitrust regulators have recently heightened their scrutiny of both horizontal and vertical merges in healthcare which could delay or prevent potential acquisitions, divestitures or a change in control'
Multiple Ongoing Litigation Exposures
Source: CHE 10-K Item 1A Risk Factors: 'We are involved in litigation incidental to the conduct of our business currently and from time to time... See the "Legal Proceedings" sections of this 10-K and the Notes to the Consolidated Financial Statements for discussion of particular matters'

Disclosed initiatives

Regulatory Compliance Programs

Company maintains internal compliance review programs, engages regulatory counsel on healthcare and franchising law compliance, and monitors adherence to FTC franchising regulations and state licensure requirements.
Cybersecurity Governance and Incident Response

Chief Legal Officer and Chief Financial Officer are designated to assess potential cybersecurity issues for materiality; company maintains incident response plans, monthly system testing, commercial cyber insurance, and vendor SOC reports.

Provides governance framework for data-breach response; limits but does not eliminate cyber risk.
Reputation Management Programs

Both Roto-Rooter and VITAS maintain reputation management risk programs to monitor brand reputation, customer reviews, and adverse publicity.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Chemed Corporation. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Chemed Corporation in the app for interactive charts and portfolio building.

More in Healthcare

Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AbbVie Inc. (ABBV) UnitedHealth Group Incorporated (UNH) Merck & Co., Inc. (MRK) Thermo Fisher Scientific Inc. (TMO)